A 9-Year Longitudinal Study of Basilar Artery Diameter.


Journal

Journal of the American Heart Association
ISSN: 2047-9980
Titre abrégé: J Am Heart Assoc
Pays: England
ID NLM: 101580524

Informations de publication

Date de publication:
05 03 2019
Historique:
entrez: 26 2 2019
pubmed: 26 2 2019
medline: 15 7 2020
Statut: ppublish

Résumé

Background Dilatation of the basilar artery ( BA ) has been recognized as a predictor of cardiovascular events ( CVE s). However, it is unclear if the longitudinal change in BA diameter (Δ BA ) is associated with CVE s. Methods and Results In a cohort of Japanese participants with vascular risk factors in an observational study, we evaluated the relationship of Δ BA to CVE s and the time course of the BA diameter. The short axis of the BA diameter was measured at the midpons level in T2-weighted images. Brain magnetic resonance imaging measurements included cerebral small-vessel disease, lacunars, and white matter hyperintensities. First, 493 patients were analyzed by the time-dependent Cox proportional hazards model to evaluate the association between Δ BA and CVE s, with adjustment for age, sex, vascular risk factors, and magnetic resonance imaging parameters. Second, we assessed the longitudinal Δ BA in 164 patients who underwent long-term follow-up magnetic resonance imaging, by linear regression analysis. In the mean follow-up of 8.7 years, 105 patients developed CVE s. A smaller Δ BA was independently associated with the high incidence of CVE s (hazard ratio, 0.36; 95% CI, 0.16-0.78; P=0.010; n=493). After a mean interval of 9.4 years, the average Δ BA was 0.41±0.46 mm (excluding patients with fetal-type circle of Willis). Progression of BA dilatation was associated with men but inversely associated with initial BA diameter and fetal-type circle of Willis (n=164). Conclusions BA diameter increased over time (excluding the patients with fetal-type circle of Willis), whereas Δ BA was inversely associated with the incidence of CVE s.

Identifiants

pubmed: 30798648
doi: 10.1161/JAHA.118.011154
pmc: PMC6474931
doi:

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e011154

Références

AJNR Am J Neuroradiol. 1986 Jan-Feb;7(1):61-72
pubmed: 3082145
Stroke. 2014 Oct;45(10):2924-9
pubmed: 25139874
Arterioscler Thromb Vasc Biol. 2013 Sep;33(9):2240-4
pubmed: 23661676
Neuroepidemiology. 2011;36(4):252-7
pubmed: 21677450
AJNR Am J Neuroradiol. 1986 Jan-Feb;7(1):55-60
pubmed: 3082144
Stroke. 2009 Jul;40(7):2552-6
pubmed: 19478233
Cerebrovasc Dis. 2007;24(1):35-42
pubmed: 17519542
Stroke. 2012 Oct;43(10):2637-42
pubmed: 22879099
Lancet Neurol. 2015 Aug;14(8):833-845
pubmed: 26194931
Lancet Neurol. 2013 Aug;12(8):822-38
pubmed: 23867200
Stroke. 1999 Dec;30(12):2671-8
pubmed: 10582995
Stroke. 2007 Apr;38(4):1197-202
pubmed: 17322076
J Stroke Cerebrovasc Dis. 2011 Sep-Oct;20(5):429-35
pubmed: 20813554
Stroke. 2016 Jan;47(1):224-7
pubmed: 26514190
J Neurol Neurosurg Psychiatry. 2004 Jan;75(1):22-6
pubmed: 14707300
J Am Heart Assoc. 2019 Mar 5;8(5):e011154
pubmed: 30798648
Stroke. 2006 Sep;37(9):2342-7
pubmed: 16888278
Stroke. 2016 Feb;47(2):434-40
pubmed: 26742795
Stroke. 2017 Sep;48(9):2361-2367
pubmed: 28754833
Cerebrovasc Dis. 2010;30(1):23-8
pubmed: 20424441
J Neurol Sci. 1993 Jan;114(1):7-12
pubmed: 8433101
Arterioscler Thromb Vasc Biol. 2005 Jul;25(7):1458-62
pubmed: 15860738
Am J Kidney Dis. 2009 Jun;53(6):982-92
pubmed: 19339088
Neurology. 2003 Dec 23;61(12):1736-42
pubmed: 14694039
Arterioscler Thromb Vasc Biol. 2013 Sep;33(9):2051-2
pubmed: 23946466
Arterioscler Thromb Vasc Biol. 2013 Feb;33(2):400-5
pubmed: 23175672
Ann Neurol. 2005 Apr;57(4):472-9
pubmed: 15739178
Eur Neurol. 2017;78(3-4):217-220
pubmed: 28903104

Auteurs

Mariko Takeuchi (M)

1 Department of Neurology and Stroke Center Osaka University Graduate School of Medicine Suita, Osaka Japan.

Kaori Miwa (K)

2 Department of Cerebrovascular Medicine National Cerebral and Cardiovascular Center Suita, Osaka Japan.

Makiko Tanaka (M)

3 Department of Stroke Medicine Hoshigaoka Medical Center Osaka Japan.

Yi Zhou (Y)

4 Laboratory of Pharmainformatics and Pharmacometrics Osaka University Graduate School of Pharmaceutical Sciences Suita, Osaka Japan.

Kenichi Todo (K)

1 Department of Neurology and Stroke Center Osaka University Graduate School of Medicine Suita, Osaka Japan.

Tsutomu Sasaki (T)

1 Department of Neurology and Stroke Center Osaka University Graduate School of Medicine Suita, Osaka Japan.

Manabu Sakaguchi (M)

5 Department of Neurology Osaka General Medical Center Osaka Japan.

Kazuo Kitagawa (K)

6 Department of Neurology Tokyo Women's Medical University Tokyo Japan.

Hideki Mochizuki (H)

1 Department of Neurology and Stroke Center Osaka University Graduate School of Medicine Suita, Osaka Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH